Alder
AcquiredBothell, United States · $94.0M raised
- Headquarters
- Bothell, Washington
- Business Model
- B2B
- Total Funding
- $94.0M
- Last Round
- $38.0M Series DApr 2012
- Rounds
- 3
About
Clinical-stage biopharmaceutical company developing migraine prevention therapies; acquired by Lundbeck for $1.95B in 2019.
Summary
Alder is a Biotech company based in Bothell, United States. It has raised $94.0M in total across 3 rounds, most recently a $38.0M Series D round in Apr 2012. Investors include Novo Holdings, Delphi Ventures and H.I.G. Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2019
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company